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Background: Although prison provides the opportunity for HIV diagnosis and access to in-prison care, following
release, many HIV-infected inmates experience clinical setbacks, including nonadherence to antiretrovirals, elevations
in viral load, and HIV disease progression. HIV-infected former inmates face numerous barriers to successful
community reentry and to accessing healthcare. However, little is known about the outcome expectations of
HIV-infected inmates for release, how their post-release lives align with pre-release expectations, and how these
processes influence engagement in HIV care following release from prison.
Methods: We conducted semi-structured interviews (24 pre- and 13 post-release) with HIV-infected inmates
enrolled in a randomized controlled trial of a case management intervention to enhance post-release linkage to
care. Two researchers independently coded data using a common codebook. Intercoder reliability was strong
(kappa = 0.86). We analyzed data using Grounded Theory methodology and Applied Thematic Analysis. We
collected and compared baseline sociodemographic and behavioral characteristics of all cohort participants who
did and did not participate in the qualitative interviews using Fisher’s Exact Tests for categorical measures and
Wilcoxon rank-sum tests for continuous measures.
Results: Most participants were heterosexual, middle-aged, single, African American men and women with histories
of substance use. Substudy participants were more likely to anticipate living with family/friends and needing
income assistance post-release. Most were taking antiretrovirals prior to release and anticipated needing help
securing health benefits and medications post-release. Before release, most participants felt confident they would
be able to manage their HIV. However, upon release, many experienced intermittent or prolonged periods of
antiretroviral nonadherence, largely due to substance use relapse or delays in care initiation. Substance use was
precipitated by stressful life experiences, including stigma, and contact with drug-using social networks. As informed
by the Social Cognitive Theory and HIV Stigma Framework, findings illustrate the reciprocal relationships among
substance use, experiences of stigma, pre- and post-release environments, and skills needed to engage in HIV care.
(Continued on next page)* Correspondence: dfhaley@emory.edu
1Department of Behavioral Sciences and Health Education, Rollins School of
Public Health, 1518 Clifton Rd., NE Atlanta, GA 30322, USA
2Department of Health Behavior, Gillings School of Global Public Health,
University of North Carolina, Chapel Hill, NC, USA
Full list of author information is available at the end of the article
© 2014 Haley et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Haley et al. BMC Public Health 2014, 14:1253 Page 2 of 15
http://www.biomedcentral.com/1471-2458/14/1253(Continued from previous page)
Conclusion: These findings underscore the need for comprehensive evidence-based interventions to prepare
inmates to transition from incarceration to freedom, particularly those that strengthen linkage to HIV care and
focus on realities of reentry, including stigma, meeting basic needs, preventing substance abuse, and identifying
community resources.
Keywords: HIV/AIDS, Incarceration, Social cognitive theory, Stigma, Qualitative research, Substance misuseBackground
A substantial proportion of HIV-infected men and
women in the United States (US) are incarcerated [1-3],
reflecting the endemicity and disproportionate burden of
incarceration in communities most affected by HIV
[4-6]. Although prison provides the opportunity for HIV
diagnosis and access to in-prison care [7-10], following
release from prison, many HIV-infected inmates experi-
ence clinical setbacks, including nonadherence to anti-
retroviral therapy (ART), elevations in viral load, and
HIV disease progression [8,10-14]. Given the high preva-
lence of HIV risk behaviors among HIV-infected former
prison inmates (“releasees”) [15-17] and the increased
risk of transmission associated with higher HIV viral
loads [18], prison release represents a critical juncture in
the health of the individual and often, his/her community.
Following release, inmates struggle to prioritize engage-
ment in HIV-related care in the face of poor access to
medical care; limited health insurance, social benefits, and
employment prospects; endemic poverty; and unstable
housing [11,13,14,19-24]. Underlying mental illness and
substance use further complicate this transition [25].
Stigma serves as an additional barrier to accessing care
for HIV-infected releasees [26-28] and experiences of
HIV-related stigma have been associated with poor
health outcomes among people living with HIV/AIDS
(PLWHA) in the US [29-31]. The negative effect of
stigma may be compounded for HIV-infected inmates,
who also bear the stigma of incarceration and often sub-
stance use disorders, mental illness, and racial minority
status [30]. HIV-infected inmates’ experiences of stigma
[29-31] and its impact on engagement in HIV care can
be informed by the HIV Stigma Framework (HSF),
which explores how individuals experience stigma, and
how these experiences affect psychological, health, and
behavioral outcomes [32]. Using this framework, stigma is
experienced by people living with HIV/AIDS (PLWHA)
through at least three mechanisms: 1) Enacted stigma
(the degree to which PLWHA believe they have experi-
enced prejudice or discrimination); 2) Anticipated stigma
(the degree to which PLWHA expect that they will ex-
perience prejudice or discrimination in the future); and
3) Internalized stigma (the degree to which PLWHA en-
dorse the negative beliefs and feelings associated with
HIV/AIDS about themselves) [32].Although there is a rich literature documenting the
challenges of HIV-infected prison inmates face upon re-
lease, less is known about how the expectations of HIV-
infected prison inmates for engagement in HIV-related
care and treatment prior to release compare to the real-
ities of the environment they face upon community reen-
try, and how potential discrepancies between expectations
and reality impact behaviors related to HIV care upon re-
lease. A richer understanding of how individual-level char-
acteristics (e.g., substance use history) interact with the
social and built environment (e.g., social networks) to in-
fluence HIV-related self-management behaviors and en-
gagement in HIV care after prison release (e.g., linkage to
care and adherence to ART) may inform the develop-
ment of multilevel interventions designed to improve
engagement in care in this vulnerable population. The
Social Cognitive Theory (SCT) posits that individuals,
their health behaviors (e.g., linkage to HIV care, adher-
ence to HIV medication), and their physical and social
environments are in constant interaction, modifying each
other and shaping future health behaviors and associated
health outcomes (reciprocal determinism) [33]. An indi-
vidual’s behaviors may be further influenced by the value
he or she places on certain outcomes (outcome expecta-
tions), and the individual’s confidence in his/her ability to
perform (self-efficacy) and to regulate (self-regulation)
these behaviors. The SCT has been successfully used to
inform HIV management (e.g., improving ART adher-
ence) in US populations [34-36] and can be applied to
HIV management following release from prison. Inmates
experience dramatic changes in their social and built en-
vironments following release; formal sanctions inherent
in the correctional environment strongly promote abstin-
ence from substance use and enforced adherence to anti-
retroviral medications (ARVs) and medical appointments.
The impact of the environment on substance use disor-
ders and engagement in HIV care comes into stark relief
upon release from prison, when competing demands,
such as the need for food and shelter, as well as the bur-
dens of poverty, addiction, and changes in mental and
physical health status may interfere with engagement in
care for HIV.
This manuscript, informed by the SCT and HSF, ex-
plores qualitatively the expectations of HIV-infected
prison inmates for engagement in HIV-related care and
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characteristics affecting their release experiences as they
relate to engagement in care, the realities of the environ-
ment they face upon community reentry, and the conflu-
ent impact of these factors on their engagement in HIV
care upon release.
Methods
Study design
We conducted semi-structured qualitative interviews
with HIV-infected men and women before and after re-
lease from prison (Figure 1). We used a convenience
sample of participants enrolled in the Bridges to Good
Care and Treatment (BRIGHT) study (design previously
described) [37], a randomized controlled trial testing the
impact of strengths-based bridging case management
(BCM) on post-release outcomes among HIV-infected
individuals released from the North Carolina Department
of Public Safety (NCDPS) Division of Adult Correction.
BRIGHT eligibility criteria included: plans to return to
one of twelve NC counties and being HIV-infected,
within 12 to 4 weeks of projected release, ≥18 years old,
and English-speaking. BRIGHT study participants were
followed up to 48 weeks after release from prison. Par-
ticipants in the control arm received NCDPS standard
of care discharge planning prior to release only. Partici-
pants enrolled in the intervention arm received BCM up
to six months following release from prison. Recruit-
ment for the qualitative substudy was initiated approxi-
mately 8 months after the start of the parent study.
Qualitative substudy eligibility criteria included: en-
rolled in parent study, pre-release, and willing/able to
provide informed consent for the qualitative interview.Figure 1 Study flow diagram.Potential participants were approached after enrollment
in the parent study, during a routine clinical appoint-
ment at the NCDPS infectious disease clinics. We
approached 28 potential participants for the qualitative
substudy during clinical appointments at the NCDPS
infectious diseases clinics, of these, 24 (86%) agreed to
participate. All study activities were approved by the
Institutional Review Boards (IRB) at the University of
North Carolina at Chapel Hill School of Medicine and
the NCDPS, as well as the Office of Human Research
Protection at the US Department of Health and Human
Services. Each participant provided informed consent
prior to study procedures. This manuscript adheres to
RAT guidelines for reporting qualitative studies.
Semi-structured interview guides
At pre-release, we assessed expectations for the release
process and post-release life, the impact release would
have on relationships with people both inside and out-
side of prison, and the role of HIV infection in post-
release life. Post-release interviews explored participants’
living situations, social networks, experiences living with
HIV, and how pre-release expectations compared to
their lived experiences.
Data collection
Interviews lasted 30 to 90 minutes and were recorded
and transcribed. Pre-release interviews took place in a
private room at a NCDPS correctional facility with only
the participant and interviewer present. Enrollment for
the qualitative substudy was stopped when saturation of
themes was apparent based on real-time review of tran-
scripts (i.e., no new themes emerged from the data).
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pre-release interviews took place within one year of
release in community settings that provided adequate
privacy (e.g., library). Participants who were reincarcer-
ated in NCDPS correctional facilities before completing
the post-release interview were interviewed in a private
room at the prison medical facility. Baseline quantitative
demographic and behavioral data (e.g., substance use,
unmet needs) were obtained at enrollment in the parent
study through researcher-administrated questionnaires.
Survey questions included standardized and modified
scales or items [37]. Unmet needs were measured using
HIV Cost and Services Utilization Study (HCSUS) instru-
ments [38], substance use was assessed with a survey de-
veloped by the Enhancing Prevention with Positives
Evaluation Center (EPPEC) [39]. Clinical markers (e.g.,
CD4 counts) were abstracted from prison medical records.
Qualitative data analysis
We developed the codebook and conducted the data
analysis using the principles of Grounded Theory meth-
odology [40,41] and Applied Thematic Analysis [42].
Two trained researchers independently coded interviews
using a common codebook, first applying open codes for
all interview statements. Codes were reviewed by the re-
search team and integrated into major salient themes by
identifying and exploring axial connections among
codes, taking into consideration code frequencies. Emer-
ging themes and resulting axial connections were then
used to construct a theoretical framework, which was
subsequently compared to existing health behavior theor-
ies to examine whether data-driven constructs reflected
existing theoretical frameworks. Data were analyzed
using Nivo9 qualitative data analysis software (QSR Inter-
national Pty Ltd. Version 9, 2010).
Intercoder reliability
We assessed intercoder reliability (ICR) using the NVivo9
ICR function early and midway through coding using
five transcripts (three pre-release and two post-release).
Codes with a kappa below 0.8 were discussed, a consen-
sus reached, and the codebook was revised as needed.
We then recoded all interviews based on the revised
codebook. The final overall kappa was 0.86.
Quantitative data analysis
To characterize the sample, we assessed medians and
interquartile ranges for continuous variables and tabu-
lated categorical variables using SAS version 9.3 (SAS
Inc., Cary, NC). We compared baseline characteristics
of: 1) the parent study participants who did not partici-
pate in the qualitative interviews (n = 81) and the quali-
tative subset (n = 23) and 2) the qualitative subset
participants who completed the pre-release interviewonly (n = 10) versus the participants who comple-
ted both the pre- and post-release qualitative interviews
(n = 13). We assessed demographics, incarceration his-
tory, alcohol and illicit substance use behaviors in the
three months prior to incarceration, HIV diagnosis and
treatment status, anticipated housing upon release, an-
ticipated needs upon release, and study intervention
condition. We Fisher’s Exact Tests for categorical mea-
sures and used Wilcoxon rank-sum tests for continuous
measures. We used a p-value of 0.1 to determine statis-
tical significance due to the small sample size. Data are
not available for one qualitative participant who com-
pleted a pre-release interview, but was withdrawn from
the study prior to release.
Results
Participants
We conducted 37 interviews (Figure 1): 24 participants
completed pre-release qualitative interviews; of those, 13
also participated in post-release interviews (three of
which were with inmates who had been reincarcerated
in NCDPS). Most of the participants were heterosexual,
middle-aged, single, African American (AA) men and
women with limited formal education (Table 1). Sub-
stance use before incarceration was pervasive. Most par-
ticipants were taking antiretroviral treatment before
release and many anticipated needing help with getting
their medications and health benefits upon release, but
did not anticipate needing help with adherence. Substudy
participants were more likely to anticipate living with fam-
ily or friends upon release (p = 0.048), and to report need-
ing help with transportation (p = 0.078) or income
assistance (p = 0.020) than other participants in the parent
study. Participants who completed both the pre- and post-
release qualitative interviews tended to be older (p = 0.027)
than those that completed the pre-release interview only.
Qualitative findings overview and theoretical framework:
Social Cognitive Theory and HIV Stigma Framework
The theoretical framework that emerged from the quali-
tative data (Figure 2) aligns with a conceptual model that
integrates the SCT and HSF. Both pre- and post-release,
participants discussed specific individual determinants
(i.e., substance use disorder, feelings about seeking HIV
care) and environmental determinants (e.g., social net-
works and neighborhood characteristics) related to their
engagement in HIV care, the interplay between them-
selves and their social and built environments (reciprocal
determinism), and the effects that each of these had on
their engagement in HIV care and health more generally.
In addition, during the pre-release interviews partici-
pants described beliefs about the importance of engaging
in HIV care following release (outcome expectations), be-
liefs around their ability to engage in HIV care and to
Table 1 Participant baseline characteristics
Cohort comparison: cohort participants not
participating in qualitative substudy versus
qualitative subset
Qualitative cohort comparison:
pre-release only versus both pre-
and post-release interviews
Non-qualitative
cohort
Qualitative
subset
Pre-release
interviews only
Both pre- and
post- interviews
(n = 81) (n = 23)a (n = 10)a (n = 13)
n (%) n (%) n (%) n (%)
Variable Median (IQR) Median (IQR) p-value Median (IQR) Median (IQR) p-value
Demographics
Age (years) 40 (33–44)b 42 (37–45) 0.318 37 (31–42) 44 (39–46) 0.027*
Black race 63 (78%) 20 (87%) 0.395 8 (80%) 12 (92%) 0.560
Married 11 (14%) 1 (4%) 0.293 1 (10%) 0 (0%) 0.435
Male gender 60 (74%) 16 (70%) 0.790 7 (70%) 9 (69%) 1.000
Less than high school education 32 (40%)c 10 (43%) 0.812 3 (30%) 6 (46%) 0.401
Heterosexual orientation 66 (81%) 19 (83%) 1.000 7 (70%) 12 (92%) 0.281
Incarceration history
Number of previous Incarcerations 3 (1–4)c 4 (2–5) 0.175 3 (2–4) 4 (2–6) 0.197
Months served for current sentence at baseline 9 (4–23) 10 (2–19) 0.473 10 (7–14) 4 (2–44) 0.950
Substance use behaviors (3 months prior to
incarceration)
Alcohol use
Frequent drinker (2–7 days/week) 43 (54%)b 10 (48%)b 0.629 3 (37%)b 7 (54%) 0.659
Frequent binge (≥5 drinks 2–7 days/week) 36 (46%)b 9 (43%)b 1.000 2 (25%)b 7 (54%) 0.367
Illicit non-injection drug use
Any 58 (73%)b 18 (86%)b 0.061 7 (87%)b 11 (85%) 1.000
Cocaine 27 (34%) b 9 (43%)b 0.457 4 (50%)b 5 (38%) 0.673
Crack 39 (49%) b 14 (67%)b 0.219 6 (75%)b 8 (61%) 0.656
Injection drug use 7 (9%)d 1 (5%)b 1.000 0 (0%)b 1 (8%) 1.000
HIV diagnosis and treatment status
Diagnosed with HIV during current incarceration 22 (28%)b 3 (13%) 0.178 0 (0%) 3 (23%) 0.229
Years since HIV diagnosis 5 (2–13)e 8 (5–13)c 0.324 7 (5–11) 9 (3–13) 0.574
Taking antiretroviral therapy 56 (88%)g 18 (86%)b 1.000 6 (75%)b 12 (92%) 0.531
CD4 Count 337 (183–573)c 397 (147–55)6 0.862 374 (158–532) 397 (147–580) 0.078
Viral <400 copies/ml 38 (48%)c 12 (52%) 0.812 4 (40%) 8 (62%) 0.414
Post-release HIV care provider identified 50 (62%) 19 (83%) 0.081 8 (80%) 11 (85%) 1.000
Anticipated housing upon release
Living with friends or family 35 (52%)f 18 (78%) 0.048 9 (90%) 9 (69%) 0.339
Homeless/transitional housingh 17 (25%)f 5 (22%) 1.000 1 (10%) 4 (31%) 0.340
Anticipated needs upon release
Securing health benefits (e.g., medicaid) 72 (95%)e 23 (100%) 0.570 10 (100%) 13 (100) 1.000
Finding a doctor 48 (63%)e 13 (56%) 0.628 6 (60%) 7 (54%) 1.000
Getting medications 64 (84%)e 22 (96%) 0.628 10 (100%) 21 (92%) 1.000
Adherence to medications 15 (20%)e 3 (13%) 0.554 1 (10%) 2 (15%) 1.000
Transportation to clinic or job 46 (61%)e 19 (83%) 0.078 7 (70%) 12 (92%) 0.281
Drug addiction treatment 27 (35%)e 12 (52%) 0.223 4 (40%) 8 (61%) 0.414
Alcohol treatment 16 (21%)e 8 (35%) 0.265 3 (30%) 5 (38%) 1.000
Finding a place to live 51 (67%)e 16 (70%) 1.000 8 (80%) 8 (61%) 0.405
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Table 1 Participant baseline characteristics (Continued)
Income assistance 61 (81%)e 22 (100%)c 0.020 9 (100%)c 13 (100%) 1.000
Getting a job 45 (59%)e 16 (70%) 0.467 8 (80%) 8 (61%) 0.405
Mental health services 26 (34%)e 8 (35%) 1.000 2 (20%) 6 (46%) 0.379
Randomized to study intervention condition 39 (48%) 13 (56%) 0.637 5 (50%) 8 (61%) 0.685
a1 participant was withdrawn from study prior to collection of baseline data. b2 missing. c1 missing. d3 missing. e5 missing. f14 missing. g17 missing. hDefined as
living in a shelter, street, halfway house, single room occupancy, welfare hotel, or unknown housing arrangements.
*p-value <0.05 indication in bold.
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egies needed to ensure engagement in HIV care and
medication adherence (e.g., goal-setting, enlisting of social
support, and self-monitoring). Furthermore, participants
described experiences with HIV-related stigma that reflect
individual attributes (i.e. internalized stigma), environ-
ments (i.e. enacted stigma) and outcome expectations (i.e.
anticipated stigma) that influenced their conscious and
subconscious decision-making about engagement in HIV
care. We present the salient themes relating to engage-
ment in HIV care that arose from the interviews pre- and
post-release with representative quotes illustrating each
overarching construct, starting first with those related to
individual and environmental determinants, followed by
themes related to anticipated engagement in HIV care,
and conclude with experiences of stigma. These domains,
comparisons of pre- and post-release themes, and rele-
vant theoretical constructs are outlined in Table 2. ForFigure 2 Theoretical framework.the purposes of this manuscript, engagement in care en-
compasses behaviors identified by participants as import-
ant components of their HIV-related medical care, most
notably, finding a doctor, attending medical appoint-
ments, securing medical and prescription benefits, and
adherence to ARVs.
Individual and environmental determinants of
engagement in HIV care
Both before and after release, participants described the
historic and present day individual- and environment-
level contexts of their lives, and ruminated on the roles
these contexts played in shaping their engagement with
HIV care both before and after this incarceration.
Pre-release perspectives
Substance use was the most salient individual-level de-
terminant associated with engagement in HIV care.
Table 2 Major themes, comparisons pre- and post-release, and relevant theoretical constructs
Major themes
Domain Pre-release Post-release Theoretical construct
Individual and
environmental
determinants
● Substance misuse was viewed as a
pervasive, negative influence which led to
ART non-adherence, poor health, fractured
family networks, and incarceration.
● Substance misuse continued to be a pervasive,
negative influence which led to non-adherence,
poor health, and fractured social networks, and
incarceration.
● SCT, Individual
Determinants,
Environmental
Determinants,
Reciprocal Determinism
● Participants were keenly aware of risk of
substance misuse relapse and its association with
poor HIV management, but unsure how to avoid
relapse.
● Participants were keenly aware of risk of
substance misuse relapse and its association with
poor HIV management, but many were unable to
avoid relapse.
● SCT, Self-Regulation/
Self-Monitoring
● Challenges with housing, stressful life circumstances,
and meeting daily needs led to relapse.
● SCT, Reciprocal
Determinism
● Substance use led to ART non-adherence, poor
health, and criminal behavior.
● SCT, Reciprocal
Determinism
● Participants desired to avoid past peer networks
and to develop new, positive social networks.
● Participants varied in their abilities to develop
positive social networks and to reconnect with
family members.
● SCT, Self-Regulation/
Enlistment of Social
Support
● Peer networks were associated with substance
use and criminal behavior.
● Participants who reconnected with past peer
networks relapsed and returned to criminal
behaviors.
● SCT, Reciprocal
Determinism
● Family networks were strained due to substance
use, criminal behavior, or HIV status.
● Participants who developed new social networks
(e.g., church groups) or reconnected with family
avoided substance misuse.
● SCT, Reciprocal
Determinism, Self-
Regulation/Enlistment
of Social Support
● Social networks had unanticipated positive role in
HIV management (e.g., transportation to
appointments, medication reminders, help
completing paperwork and securing benefits.
● SCT, Reciprocal
Determinism, Self-
Regulation/Enlistment
of Social Support
HIV
management
● Participants viewed HIV management as an
important part of staying healthy and motivation
to avoid substance misuse.
● Participants viewed HIV management as an
important part of staying healthy, but HIV care
was often eclipsed by substance misuse.
● SCT, Outcome
Expectations
● Participants expressed confidence in their ability
to adhere to ART and to manage their HIV.
● Many participants described periods of ART non-
adherence and poor health, largely due to
substance misuse relapse.
● SCT, Self-Efficacy
● Participants who had been diagnosed with HIV
during previous incarcerations felt they could easily
find a doctor, but were worried about paying for
medications if they could not find a job.
● Challenges finding employment and meeting
basic needs were greater than anticipated. Many
participants reported unforeseen challenges in
completing paperwork and securing benefits.
● SCT, Outcome
Expectations,
Reciprocal
Determinism
● Social networks had unanticipated positive
role in HIV management (e.g., transportation to
appointments, medication reminders, help
completing paperwork and securing benefits.
● SCT, Reciprocal
Determinism, Self-
Regulation/Enlistment
of Social Support
● Newly diagnosed participants were hesitant to
access medical care following release due to fears
of HIV disclosure.
● Participants continued to be concerned about
disclosure, some accessed HIV-related medical
care, others did not.
● SCT, Outcome
Expectations HSF,
Anticipated Stigma
Stigma ● Participants recounted numerous counts of
experienced HIV-related stigma including losing
jobs, rejection by family and friends, public dis
closure and harassment which occurred both
prior to and during their current incarceration.
● Participants recounted numerous counts of
experienced HIV-related stigma and additional
stigma associated with criminal history, including
losing jobs, rejection by family and friends, public
disclosure, and harassment.
● HSF, Enacted Stigma
● Participants rejected HIV-related services due to
fears of HIV disclosure.
● Participants continued to avoid HIV-related
services due to fears of HIV disclosure.
● HSF, Anticipated
Stigma SCT, Outcome
Expectations
● Participants expressed shame and embarrassment
about their HIV status.
● Participants expressed shame and embarrassment
about their HIV status and/or their substance
misuse relapse.
● HSF, Internalized
Stigma SCT, Outcome
Expectations
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fluence that was closely linked to the breakdown of their
family relationships, experiences of violence, and ultim-
ately their exposure to and difficulties managing their
HIV. As one woman stated: “when I relapse I don’t take
my medicine. And that’s not good. The last time I re-
lapsed I didn’t take my medicines.” [−AA Female in her
30s]. Although participants self-monitored the relation-
ship between their substance use, engagement in HIV
care, and health, many expressed low self-efficacy in
their abilities to prevent their substance use relapse fol-
lowing release. For example, one participant acknowl-
edged her relapse patterns but was unsure how to avert
them, saying:
Every time I get out I do good until like three or four
months, and then… I start to relapse. I’m thinking, I
don’t know what’s causing me to want to go and do
those [drugs]…It’s scary. I don’t know how I am going
to handle it, you know, when a problem comes my
way. If I’m going to turn to drugs- you know, how I’m
going to handle it. -AA Female in her 30s.
Participants perceived the environments to which they
were returning to be rife with obstacles to good health,
as exemplified by one participant:
I have to go back to [father’s]…he’s still doing drugs.
You know, I know it is not a very safe environment….
I’m scared about it you know… because I don’t want
to go back to drugs. That’s what I don’t want. Right
now I am doing good on my situation, my sickness
[HIV]…I ain’t trying to be dying and it could influence
my mind about the drugs, going back to the drugs. –
Latino Male in his 30s.
Most participants described chaotic pre-incarceration
environments and fractured family relationships to
which they often responded by engaging in violent and
illegal activities, including substance use. One man
reflected that his mother’s absence during his youth re-
sulted in his approach to solving challenging situations
as an adult, noting: “I ended up… doing a lot fighting [as
a child], getting in a lot of violence all the time and so
that violence carried on. That’s how I deal with things
now when I am threatened with something”. [−AA male
in his 50s]. Notably, many participants’ pre-incarceration
social networks revolved around substance use. Relation-
ships with members of networks they perceived to be
more wholesome, such as non-using family, were often
strained (due to substance use and/or their incarcer-
ation), diminishing some participants’ perceived access
to relationships that would support them in avoiding re-
lapse following prison release, as exemplified here: I hada good relationship with my family…they told me in the
beginning, you know: ‘if I got into that there [drugs, il-
legal activities], don’t depend on no help from them and
stuff.’ And I chose the wrong ways”. [−AA Male in his
40s] Some felt that it was “too late” due to severed bonds
or a family member’s death during the participant’s in-
carceration while others were more hopeful and actively
working to repair such relationships.
Post-release perspectives
The post-release interviews revealed complex interac-
tions between individual factors (e.g., substance use) and
post-release social and built environments. As partici-
pants anticipated, following release, substance use pre-
sented an acute challenge for most and hence emerged
as a salient theme. Those who did relapse associated
their drug use with nonadherence and poor health (e.g.,
weight loss) as illustrated by one participant, who stated:
“Man, in the streets if you’re out there on drugs [illicit]
and stuff like that there, you might [not] take your me-
dicine. You might [not] eat.” [−AA Male in his 40’s].
Substance use was often precipitated by both individual-
level and environmental determinants, including associa-
tions with former substance using networks, stressful life
events, or survival needs, as described by one man:
You know, I came home and I needed some things…I
tried to go get a voucher…I couldn’t get any…So, I met
some friends…I said ‘I need y’alls help…They were
dopers…They know I sell dope. They knew I knew
dope. That’s what I knew. I sell it. I sell that dope,
that’s what I do. -AA male in his 40s.
Participants’ experiences with substance use and ul-
timately, their engagement in HIV care, were intertwined
with the post-release environment, particularly housing
situations. Homelessness, and housing insecurity more
generally, was a predominant theme throughout the
post-release interviews. Participants avoided shelters
when possible, which they feared would connect them
with negative peer influences, and described prolonged
periods of transition, such as moving between friends
and family, or staying in single room occupancy (SRO)
hotels for as many nights as they could afford before
returning to the streets. Participants saw a direct con-
nection between the safety of their neighborhood envir-
onment, substance use relapse, and their engagement in
HIV care. As one man described:
I really didn’t have anything…I stay[ed] in an
abandoned building or under the bridge or even an
abandoned car…You know, sleeping in areas and stuff
like that, you never know what might happen. You
doze off to sleep, there’s no telling who might come
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would pick up, use. -AA Male in his 40’s.
While this participant went on to describe stopping
his ARVs as a result of this relapse, he also discussed
that when he entered a long-term residential substance
use treatment program which provided structured pro-
gramming, long-term housing, and facilitated formation
of new social networks, his cravings to use diminished
and his medication adherence improved.
As in pre-release interviews, participants described
both the positive and negative role of social networks
following release. Participants who had reestablished re-
lationships with non-substance using family members or
developed new networks through Narcotics Anonymous
(NA) or religious groups found the support they needed
to avoid negative influences, noting:
And, as I say, I’ve got support with my church, my
family, you know, NA groups…It was a struggle at
first… I couldn’t have did it without my support
systems that I’ve got, my family and my church…So, I
had to avoid my old friends and get some new friends.
And that was kind of hard because I was so used to
those old friends. -AA female in her 30s.
Most participants who experienced substance use re-
lapse, and all who were reincarcerated post-release, at-
tributed these negative outcomes to their substance using
social networks. Although these participants expressed
pre-release the need to connect with “positive-thinking
people”, once released, they discussed being unable to en-
gage with new networks. As this participant related:
Well, the tipping point was, OK, I was home for like
60 days trying my best not to do nothing ‘cause I was
glad to be out…Then I got around those guys again.
That was it. When I got around those guys again, into
the same playground, the same playmates….I never
really ever thought about ‘how do I find positive
people.’ I don't know. I’m so used to being around
negative people, you know. -AA male in his 40s.
A number of participants either did not have relation-
ships with family members or did not disclose their HIV
status to family members following release. However, al-
though not anticipated pre-release, following release,
participants who had disclosed their HIV status to sup-
portive family or friends noted that these relationships
provided important support for linkage to care and
medication adherence. One woman described how fam-
ily members reminded her to take her ARVs, saying:
“He’ll hand me my medicine and he’ll get me a bottle of
water and then he’ll say ‘I know you’ve got to have this.’”[−AA Female in her 40s]. Several participants, particu-
larly those with low literacy, described how family mem-
bers had helped them get to appointments and navigate
paperwork associated with reinitiating HIV-related bene-
fits as illustrated by this quote:
[I] went to a couple clinics. And me and my niece, we
signed a couple papers…She went to college. She’s very
smart…I can read and write a little bit, so I can go to
her and say ‘well, I’m going to see these people and I
need to sign these papers and they help to get my
medication. Help me fill out the application…I need
health care.’ She got it for me. -AA Male in his 40s.
While such family support helped, unanticipated admin-
istrative barriers (e.g., time required to process paperwork)
often hindered timely linkage to care; these barriers were
particularly salient for low literacy participants who had
limited or no outside help navigating administrative sys-
tems. Even those who successfully accessed HIV services
faced significant challenges to securing employment and
housing, and as a result, their struggles to meet basic
needs hindered health care access.
Anticipated and actual outcomes: engagement in
HIV care
Emergent themes about engagement in HIV care, de-
scribed below, revealed a complex juxtaposition between
what participants anticipated their engagement in HIV
care would be like when they reentered their community
and their actual behaviors and engagement in HIV care
following release.
Pre-release perspectives
During the pre-release interviews, participants expressed
high self-efficacy for medication adherence and positive
outcome expectations for engagement in HIV care. They
saw themselves readily attending HIV-related medical
care appointments, taking medication, and maintaining
their health more generally (e.g., eating well) as would
be needed to avoid becoming too sick to work or care
for themselves or others, or even dying. Many believed
their HIV diagnosis motivated them to avoid drugs and
alcohol, as illustrated here:
Someone who is not positive, they wouldn’t think too
much about needing to stay healthy and exercising.
They wouldn’t take it as seriously. They wouldn’t take
drugs and alcohol, staying off that, as seriously. It
wouldn’t be a real death blow to them as it is me.
-AA Man in his 40s.
Participants diagnosed before this incarceration felt
confident they would be able to find an HIV care
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their medications if they could not secure a job or bene-
fits. In contrast, people diagnosed during this incarcer-
ation expressed low self-efficacy for finding a doctor and
initiating HIV care after release. For these participants,
their confidence in their ability to initiate HIV care was
undermined by concerns that accessing such care could
disclose their serostatus to others (e.g., anticipated
stigma). As one man exemplified:
[W]hat am I going to do when I get out? Do I have to
go see the doctor, do I have to go see the medical
people? What will people think about me? What will
people do?…I might be in a room and pick up my
meds and people say ‘Hey, hey. What you doing up
here?’ -AA Man in his 30s.
Post-release perspectives
Following release, participants continued to emphasize the
importance of linking to HIV care and medication adher-
ence as part of maintaining their overall health. As one
participant described: “As long as I take the medicine and I
do what I’m supposed to do, I live, I’m living a normal life.
Blood pressure, excellent. Pulse, excellent. Respiration, ex-
cellent. All that stuff is in good shape. No problem!” [−AA
Man in his 40s]. However, participants’ ability to success-
fully attend medical appointments and adhere to ARVs
was ultimately intertwined with their substance use; which
was in turn a function of social interactions, including ex-
periences of stigma and stressful life events. As noted pre-
viously, several participants described being nonadherent
to medications when experiencing short or prolonged pe-
riods of substance use relapse. Despite their keen aware-
ness of and concerns about the impact of nonadherence
on their health, taking their ARVs was eclipsed by their
addiction. As one participant explained:
When I was on the street I was drinking and drinking.
But back in my mind I was thinking ‘damn, you’re
speeding up the process! You’ll be in a casket real
soon.’ But I’m so addicted…I tried that [taking ARVs]
for a while. But it makes you feel so nauseated. It
makes it very hard. -AA Man in his 30s.
Experiences with HIV-related stigma
Experiences with stigma emerged as a cross-cutting,
multilevel theme. Every participant described experi-
ences of HIV-related stigma, including enacted stigma,
anticipated stigma, and internalized stigma both pre-
and post-release [32].
Pre-release perspectives
Participants described numerous episodes of experien-
cing enacted stigma prior to and while incarcerated.These included being fired from jobs as a result of HIV
disclosure; rejection by family, friends and community
members; and public disclosure and harassment on the
prison yard. Memories of these experiences were so
painful that some participants felt unable to return to
specific neighborhoods. The deleterious effect of experi-
ences of enacted stigma on participants’ well-being are
exemplified by this man:
I came back to the yard [from the prison infectious disease
clinic] and everyone was saying…that I had HIV… I was so
upset, I went and to the individual that was talking to the
yard about my medical condition…sometimes people are
naïve to AIDS, you know, and it just got all over the yard…I
was quite upset about it…There was one guy on the yard
that was saying it and he has the same thing that I have. I
know he does, ok. Alright. I’m not dumb ok, but I didn’t take
his business to the yard. I didn’t, but in return he took my
business to the yard…I felt stabbed in the back. -AA Male in
his 40s.
Some participants displayed anticipated stigma: they
self-isolated and hesitated to accept available HIV-
related services in order to avoid HIV disclosure and its
potential stigma. One woman, who had been diagnosed
during her current prison sentence, chose uncertain
housing over arranging to go to a halfway house for
people with HIV after release:
A halfway house is definitely out because, like I said,
I’ve been in recovery before and all the halfway houses
in the city…they’re known to be boarding them with
AIDS and, you know, the stigma. You know, I mean
‘That’s that woman with HIV. That’s the house where
they have AIDS’…I want to be known for who I am
and not what I have, you know? It’s a difficult time.
-AA Female in her 40s.
Participants also experienced internalized stigma, noting
that they “tried not to think about it [HIV]” or felt shame
around their HIV status, as one woman described: “I don’t
want nobody to know nothing, nothing about this because I
am embarrassed…I don’t want people to turn away from
me and stuff thinking that I have something that is conta-
gious.” [−AA Female in her 40s].
Post-release perspectives
Following release, participants also described a range of ex-
periences with HIV-related stigma, the majority of which
were enacted. One participant was fired because he was
seen entering a local AIDS Service Organization (ASO):
I ended up getting a job and then someone seen me
going around [ASO] and then it got back to my job.
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hide it… But the man who owns, he had a real
problem with it…I’m not welcome around that store
anymore. -Native American Male in his 30s.
Participants experienced additional layers of enacted
and internalized stigma due to other stigmatizing condi-
tions (e.g., incarceration, substance use) that they de-
scribed negatively affecting their ability to prioritize HIV
care including: profiling by law enforcement, rejection
from jobs, denial of housing or benefits, public harass-
ment, and shame surrounding substance use. One man
avoided seeking HIV care because he felt ashamed of his
appearance when he relapsed, saying: “Lots of programs
were there, you know, agencies and stuff like that but I
wasn’t coming out into the public. You know, when I’m
[using], I look, my appearance and stuff like that, nah, I
wasn’t coming out.” [−AA man in his 40s]. Another man
described being singled out during a job training pro-
gram because of his criminal record: “One guy’s wife in
the program…she picked on me. ‘I don’t know who gonna
hire you.’ She was very discouraging to me.” [−AA Man
in his 50s]. The same participant described how this
experience, combined with the challenging training, low-
ered his self-esteem, led him to reconnect with sub-
stance using networks, and to ultimately relapse and
stop taking his HIV medications. Participants had vary-
ing experiences related to stigma from family and friends
following release from prison. One participant who, be-
fore release, had described how her father, upon learning
her serostatus, had kicked her out of their house, talked,
after release, about how her sobriety helped her and her
father rebuild their relationship.
Discussion
These findings underscore the competing demands
weighing on many released inmates, and highlight how
engagement in HIV care, while valued as important by
most HIV-infected prisoners, may become eclipsed by
more immediate concerns (e.g., addiction, homeless-
ness). Participant descriptions of the release process and
their lives post-release overwhelmingly highlighted nu-
merous acute challenges, including the difficulties man-
aging their personal circumstances and environmental
pressures while avoiding substance use relapse and crim-
inal activity. When viewed within the framework of SCT
and the HSF, these results illuminate the contrast be-
tween the anticipated release environment and the even
more difficult realities of this tumultuous period, and
the role of self-efficacy and regulatory behaviors in navi-
gating these challenges. This study adds to our under-
standing of engagement in HIV care among recently
released HIV-infected prison inmates in the following
key ways: 1) It is one of the first theory-guided studiesto qualitatively explore relationships between pre-release
and post-release expectations for engagement in HIV
care following release from prison; and 2) is among the
first studies to identify how experiences of compounded
stigma influence engagement in HIV care following re-
lease from prison.
For HIV-infected inmates, linkage to HIV care and
treatment cannot be implemented without an acknow-
ledgement of the role that substance use plays in effect-
ive HIV management [43-45]. Viewed within the context
of the SCT, substance use disorders and cycles of sub-
stance use relapse, treatment, and remission colored
every aspect of the individual’s interaction with his or
her environment and ultimately affected adherence and
accessing services. Substance use among individuals with
a history of incarceration in jail and prison is common
[25,44,46]. In this study, relapse was triggered by stress-
ful life situations, such as homelessness, reintegration
with substance using networks, experiences of enacted
stigma, and economic pressures. Traditional safety nets,
such as homeless shelters, may be destabilizing through
exposure to negative peer networks. Active alcohol and
other drug use has been associated with medication
nonadherence, including among individuals entering jail
and the homeless [46-49]; this finding was echoed in the
qualitative interviews. However, treatment of substance
use disorders is associated with medication adherence
and engagement in care; treatment may allow people
who use drugs to achieve parity in HIV treatment out-
comes, as compared to people who do not use drugs
[50]. Holistic programming that incorporates the role
that past experiences, such as childhood trauma, play in
current life choices, while also focusing on evidence-
based approaches for the treatment of substance use dis-
orders (including medication-assisted therapies), individ-
ual skill and resource development (e.g., securing
housing, identifying non-using social networks) may re-
duce substance use relapse [51-53]. Our findings under-
score the need for such programming, particularly
among HIV-infected inmates. Despite the evidence sup-
porting substance use disorder treatment as a means to
improve engagement in HIV care, a small percentage of
releasees nationally are linked to substance abuse treat-
ment either in prison or upon release, and in-prison
substance use disorder treatment programs are curtailed
by a lack of funding and the relatively short sentences of
some offenders [54]. Treatment may be further com-
plicated by the lack of medication-assisted therapies
for people who use cocaine or crack. Crack and cocaine
use was reported by the majority of substudy par-
ticipants prior to incarceration (67% and 43% respect-
ively); other studies have found prevalent use of crack/
cocaine in HIV-infected individuals entering and leaving
jails [44,46].
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volvement in positive social networks as playing an im-
portant role in avoiding substance use and criminal
activity [43,55-57]. This was particularly relevant for par-
ticipants who received instrumental and emotional sup-
port with respect to their engagement in HIV care. Social
support systems have been associated with positive HIV-
related outcomes, as reflected in our qualitative data
[49,58], however, many participants struggled to identify
new social networks upon release. Stigma and other fac-
tors related to incarceration may inhibit family-based so-
cial network supports for many HIV-infected inmates,
highlighting the importance of enlisting social networks
outside of family (e.g., church, NA). Employment-based
programs offer the potential to integrate skills develop-
ment while helping former inmates to learn to navigate
“real world” contexts, build new social networks, and dem-
onstrate self-efficacy [59]. Evaluation of vocational pro-
gramming for ex-offenders has been hampered by a lack of
intervention programming with a strong research design
[60,61]. In response, several national level job development
programs are currently being implemented and evaluated,
although the vast majority focus only on men [62].
Over 80% of participants were on ART prior to release
and almost all participants reported needing help secur-
ing medical benefits (e.g., Medicaid) or getting medica-
tions upon release. Although at pre-release participants
expressed high self-efficacy for linking to care and ad-
herence to HIV medications after release, prior analyses
of this cohort revealed that roughly half of participants
had not accessed medical care within four weeks of re-
lease, at which time ARVs provided by the NCDPS upon
release would be exhausted [37]. Similarly, other studies
have found low linkage to HIV care among HIV-infected
jail and prison releasees [13,24,63,64]. These findings
suggest that confidence (self-efficacy) may not translate
to engagement in HIV care following release, particularly
if lived experiences differ from outcome expectations.
Inmates may benefit from programming that addresses
outcome expectations for engagement in HIV care upon
release, potential barriers to meeting these expectations
(e.g., social interactions, substance use relapse), and the
concrete skills and behaviors (self-regulation strategies)
required to engage in care when faced with the realities
of life upon release. For example, releasees may not have
sufficient health literacy skills, photo identification,
phone access to navigate the process of reestablishing
care, or underestimate the paperwork burden required
to do so. Past research suggests that HIV-infected in-
mates who receive help completing paperwork following
release are more likely to fill ARV prescriptions [13].
Limited research has explored the role of stigma on
HIV-related outcomes for former HIV-infected prison
inmates [21,26-28]. Notably, although the qualitativeinterview guide used for this study did not include ques-
tions or probes specifically related to stigma, participants
described countless experiences with stigma that both
directly and indirectly affected their ability to success-
fully engage in HIV care and treatment. These findings
suggest that low uptake of HIV care by HIV-infected in-
mates following release from prison may in part stem
from fear of stigma, either due to past experiences or in-
ternalized feelings. Similarly, stigma may also prevent
HIV-infected inmates who are not eligible for traditional
safety net benefits due to their criminal history from
accessing needed support through AIDS-specific resources
(e.g., housing). Roughly 25% of participants anticipated
being homeless upon release. Homelessness or other tran-
sitory living situations may make it more difficult to estab-
lish and maintain care [14,64] and has been associated
with increased sexual risk, substance use, and poor HIV-
related outcomes [16,48,65-67]. A richer understanding of
the role of stigma, particularly the intersectionality of
non-HIV-associated and HIV-associated stigmas that
HIV-infected prisoners experience, on barriers to linkage
and retention in care is needed to inform the design of
future programming for HIV-infected releases.
This study is one of the first to explore HIV-infected
inmates’ pre-release outcome expectations for engage-
ment in HIV care post-release and how these percep-
tions compared with actual experiences post-release.
This is a preliminary step in designing programs that en-
compass the transition from prison to the community,
and bridge the gap between HIV-infected inmates’ needs
(both perceived and real) and their ability to engage in
HIV care throughout this transition. Study findings
should be interpreted in light of the small sample size,
which was collected using convenience sampling. How-
ever, past research has indicated that eight interviews
are sufficient for saturation [68] and the qualitative sub-
sample did not differ significantly from the overall co-
hort for the majority of baseline measures. In addition,
participants received either pre-release discharge plan-
ning (standard of care for the state of NC) or intensive
case management (study intervention). It is possible that
participants were more acutely aware of their anticipated
needs following release or had more of these needs met
following release as a result of discharge planning or
case management. We are unable to speak to the release
experiences of participants that did not complete the
post-release interview, but based on baseline data, those
who and did not follow-up had few discernable differ-
ences in regards to their demographic characteristics
and self-reported needs.
Conclusion
Given high recidivism rates among incarcerated popula-
tions in general and poor HIV-related outcomes for
Haley et al. BMC Public Health 2014, 14:1253 Page 13 of 15
http://www.biomedcentral.com/1471-2458/14/1253HIV-infected inmates after release, a fundamental dis-
connect exists between an individual’s expectations of
life and the actual outcome after release. This disconnect
may be due to the difficulty of exerting self-influence over
the competing pressures of the reentry environment and
changing personal circumstances. Taken together, these
findings highlight the challenges HIV-infected inmates
face upon release and the need for multicomponent HIV
linkage and care programming which extends pre- and
post-release and addresses: 1) evidence-based substance
use disorder treatment; 2) stigma; 3) environmental factors
that precipitate relapse (e.g., homelessness); 3) outcome
expectation management between pre-release expecta-
tions and the realities of release, and; 4) practical problem-
solving and skill development. In addition, there is need
for future research that explores the conscious and sub-
conscious effects of layered stigma on engagement in
HIV care among HIV-infected inmates and ways to
minimize the corrosive effects of stigma on successful
community reentry and well-being. The attainment of
these goals has the potential to enhance not only the
well-being of HIV-infected inmates, but that of the com-
munities to which they return.
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